Facebook
Twitter
LinkedIn
Forward
Hidradenitis Suppurativa Clinician-Patient Summit
Hidradenitis suppurativa has significant impacts on patients’ quality of life, however, it remains underdiagnosed, misdiagnosed, or incorrectly treated. Until recently, there was a scarcity of evidence about long-term management strategies and no evidence-based consensus guidelines. The updated North American guidelines, as well as the growing armamentarium of agents in advanced clinical development, provide additional guidance for optimizing diagnosis and treatment of HS patients. However, questions still remain about how to best individualize therapy and work as a partner with patients to build a treatment plan. As such, clinicians that treat patients with HS would benefit from hearing the patient perspective in regard to gaps in care and what clinicians can change in their practice to improve patient outcomes and satisfaction. This engaging clinician-patient summit, held in partnership with HS Connect and the HS Foundation, addresses patient concerns and clinician strategies for early diagnosis and assessment of HS symptoms, treatment plan design, and shared decision-making.
Target Audience
This activity is designed for an audience of physicians, nurses, pharmacists, and other advanced practice providers (nurse practitioners/physician assistants) in medical practices that specialize in dermatology.
Learning Objectives
Upon completion of the educational activity, participants should be able to:
- Interpret the different strategies and criteria for early diagnosis and accurate assessment of disease severity in HS.
- Review the evidence-based approaches for the treatment of HS, including biologic agents, and their role in long-term disease management.
- Discuss practical strategies for improved patient-clinician communication, including shared decision-making and patient-centered care.
- Patient Panel – Living with HS
- Provider Panel – Treating HS and Addressing Barriers to Care
- Patient Perspective – Final Thoughts from Our Patients
- Key Takeaways and Next Steps
Jennifer L. Hsiao, MD
Department of Dermatology
Keck School of Medicine
University of Southern California
Los Angeles, CA
Joslyn S. Kirby, MD, MS, Med
Department of Dermatology
Penn State Milton S. Hershey Medical Center
Hershey, PA
Christopher J. Sayed, MD
Department of Dermatology
University of North Carolina at Chapel Hill
Chapel Hill, NC
Credit provided by AKH Inc., Advancing Knowledge in Healthcare
In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and Tarsus Cardio dba LiVDerm. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician
AKH Inc., Advancing Knowledge in Healthcare designates this enduring material for a maximum of 2 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses
2 ANCC contact hours.
Pharmacists
AKH Inc., Advancing Knowledge in Healthcare designates this continuing education activity for 2 contact hours.
Commercial Support
This activity is supported by an independent medical education grant from Incyte Corporation.
DISCLOSURES |
|
|
Name | Relationship(s) | Organization(S) |
Jennifer L. Hsiao, MD
| Consultant | AbbVie, Aclaris, Boehringer Ingelheim, Novartis, UCB |
Speaker | AbbVie | |
Joslyn S. Kirby, MD, MS, MEd | Advisory Board | AbbVie, Incyte, Novartis, UCB |
Consultant | AbbVie, Alumis, DermTech, Guidepoint, Incyte, Insmed, Janssen, Moonlake, Novartis, UCB | |
Speaker | AbbVie, Novartis, UCB, Janssen | |
Christopher J. Sayed, MD | Consultant | Incyte, UCB, Abbvie, Novartis, Astrazeneca, Sonoma Biotherapeutics, Alumis |
Researcher | Incyte, UCB, InflaRx, Novartis, Chemocentryx, Abbvie | |
Speaker | Abbvie, Novartis | |
Brindley Brooks – Patient | N/A | Nothing to disclose |
Cydney Carter – Patient | N/A | Nothing to disclose |
Joey Torre – Patient | N/A | Nothing to disclose |
Selina Ferragamo, Master of Science - Patient | N/A | Nothing to disclose |
Dorothy Caputo, MA, BSN, RN, Healthcare CE and Operations | N/A | Nothing to disclose |
Michele Bielarski, RN (planner/reviewer) | N/A | Nothing to disclose |
Dorothy Duffy, RPh, Pharmacy Reviewer | N/A | Nothing to disclose |
AKH Inc Staff and Planners | N/A | Nothing to disclose |
Tarsus dba LiVDerm Staff and Planners | N/A | Nothing to disclose |
All of the relevant financial relationships listed for these individuals have been mitigated. | ||
Disclosures
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.
Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant’s misunderstanding of the content.
AKH Privacy Policy (link: https://akhcme.com/akhcme/pages/privacy)
Available Credit
- 2.00 ACPE Pharmacy
- 2.00 AMA PRA Category 1 Credit™
- 2.00 ANCC
- 2.00 Participation
Required Hardware/software
A computer with an internet connection
Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
Other additional software may be required such as PowerPoint or Adobe Acrobat Reader.
AKH Privacy Policy (link: https://akhcme.com/akhcme/pages/privacy